Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -217,201 | 36,908 | -102,496 | -88,720 | -75,738 |
| Depreciation Amortization | 126,710 | 128,303 | 124,917 | 127,048 | 101,366 |
| Income taxes - deferred | N/A | N/A | N/A | 23,632 | -41,354 |
| Accounts receivable | -5,533 | 35,271 | 30,107 | -30,902 | -43,609 |
| Other Working Capital | -606 | -107,198 | 18,338 | -17,073 | 129,832 |
| Other Operating Activity | 187,105 | -20,787 | -8,699 | 57,278 | 81,873 |
| Operating Cash Flow | $90,475 | $72,497 | $62,167 | $71,263 | $152,370 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,481 | -5,282 | 66,171 | -2,860 | -1,715 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -1,050,011 |
| Purchase Of Investment | -12,065 | 0 | -8,277 | -68,818 | -116,209 |
| Sale Of Investment | 12,065 | -1,800 | 0 | 117,214 | 84,884 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -25,000 |
| Investing Cash Flow | $-1,481 | $-7,082 | $57,894 | $45,536 | $-1,108,051 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 562,063 |
| Debt Repayment | -150,000 | -82,500 | -110,000 | -100,000 | 0 |
| Common Stock Issued | 251 | 2,020 | 8,940 | 9,951 | 10,398 |
| Other Financing Activity | -8,087 | -870 | -9,826 | -10,125 | -4,364 |
| Financing Cash Flow | $-157,836 | $-81,350 | $-110,886 | $-100,174 | $568,097 |
| Beginning Cash Position | 110,949 | 126,884 | 117,709 | 101,084 | 488,668 |
| End Cash Position | 42,107 | 110,949 | 126,884 | 117,709 | 101,084 |
| Net Cash Flow | $-68,842 | $-15,935 | $9,175 | $16,625 | $-387,584 |
| Free Cash Flow | |||||
| Operating Cash Flow | 90,475 | 72,497 | 62,167 | 71,263 | 152,370 |
| Capital Expenditure | -1,481 | -5,507 | -666 | -2,860 | -1,715 |
| Free Cash Flow | 88,994 | 66,990 | 61,501 | 68,403 | 150,655 |